WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke GENIAPORE wurde als Wortmarke am 16.01.2020 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1518503 |
| Länder | 
|
| Basismarke |
Nr. 018136263,
11. Oktober 2019
|
| Anmeldedatum | 16. Januar 2020 |
| Ablaufdatum | 16. Januar 2030 |
Markeninhaber
Sandhofer Str. 116
68305 Mannheim
DE
68305 Mannheim
DE
Markenvertreter
Grenzacherstrasse 124
4070 Basel
CH
Waren und Dienstleistungen
09
Scientific, genomic, measuring and data processing
apparatus, devices and instruments; apparatus, devices and
instruments for identifying, sequencing, analyzing,
measuring and/or recording DNA or other molecules (for
non-medical purposes); laboratory devices for use in
research and science; laboratory instruments, namely,
devices for analysis of nucleic acids and for DNA
sequencing; nucleic acid sequencers; imaging devices and
analyzers; genotyping and gene expression microarrays,
associated mapping files and associated kits for analyzing
nucleic acids for scientific, pharmaceutical and medical
research purposes; software for scientific, pharmaceutical
and medical research purposes; computer systems and software
for collecting, storing, analyzing and reporting biological
information, and for sample tracking and managing projects,
laboratory workflow and data, for use in the fields of
scientific, diagnostic and clinical research and for
clinical diagnostic purposes; software for use in analyzing,
managing and visualizing DNA sequencing data
10
Medical apparatus, devices and instruments; diagnostic and
testing apparatus, devices and instruments for medical
purposes; apparatus, devices and instruments for
identifying, sequencing, analyzing, measuring and/or
recording DNA or other molecules for medical purposes;
diagnostic and analytical apparatus for medical purposes;
medical equipment, namely, devices for analyzing nucleic
acids and for DNA sequencing for the purpose of rendering
medical treatment and diagnosis
42
Scientific research and consultancy services related
thereto; scientific research and consultancy services
related thereto in the fields of genome sequence analysis
and reporting; medical research services; providing DNA
screening for scientific research purposes; providing
diagnostic services for others in the fields of science and
research related thereto; consulting services in the field
of cloud computing in the fields of life science; technical
support services, namely, infrastructure management services
for monitoring, administration and management of cloud
computing IT and application systems in the fields of life
science; computer services, namely cloud hosting provider
services for storing, analyzing and sharing data in the
fields of life science; providing online non-downloadable
software for the custom design and ordering of assays and
reagents; design and development of laboratory instruments
and computer systems for use in science and clinical
research; consultancy, information and advisory services in
the field of analysis of biomolecules
44
Medical services for analysis of genetics; genetic testing
for medical purposes; nucleic acid based testing for medical
purposes; medical services in the field of nucleic acid
analysis; medical services in the field of genetic
screening
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 15. März 2023 | 2023/12 Gaz | CA | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 26. November 2021 | 2021/48 Gaz | KR | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 26. August 2021 | 2021/35 Gaz | JP | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| 19. August 2021 | 2021/33 Gaz | TR | Ablehnung |
| 19. August 2021 | 2021/34 Gaz | TH | Ablehnung |
| 08. Juli 2021 | 2021/29 Gaz | CA | Ablehnung |
| 05. Juli 2021 | 2021/27 Gaz | MY | Ablehnung |
| 20. April 2021 | 2021/22 Gaz | RAW: Limitation | |
| 15. April 2021 | 2021/15 Gaz | JP | Ablehnung |
| 25. März 2021 | 2021/13 Gaz | IS | Ablehnung |
| 04. März 2021 | 2021/10 Gaz | VN | Ablehnung |
| 03. März 2021 | 2021/9 Gaz | UA | Ablehnung |
| 01. März 2021 | 2021/10 Gaz | IL | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 25. Februar 2021 | 2021/8 Gaz | NO | Ablehnung |
| 19. Februar 2021 | 2021/8 Gaz | AM | Ablehnung |
| 08. Februar 2021 | 2021/6 Gaz | KZ | Ablehnung |
| 03. Februar 2021 | 2021/11 Gaz | RAW: Limitation | |
| 27. Januar 2021 | 2021/4 Gaz | CH | Ablehnung |
| 30. Dezember 2020 | 2021/1 Gaz | KG | Ablehnung |
| 28. Dezember 2020 | 2021/1 Gaz | KR | Ablehnung |
| 01. Dezember 2020 | 2020/49 Gaz | BY | Ablehnung |
| 01. Dezember 2020 | 2020/49 Gaz | IN | Ablehnung |
| 10. November 2020 | 2020/46 Gaz | BR | Ablehnung |
| 20. Oktober 2020 | 2020/43 Gaz | CO | Ablehnung |
| 17. September 2020 | 2020/38 Gaz | SG | Ablehnung |
| 17. September 2020 | 2020/38 Gaz | AU | Ablehnung |
| 01. September 2020 | 2020/36 Gaz | NZ | Ablehnung |
| 18. August 2020 | 2020/35 Gaz | GB | Ablehnung |
| 10. August 2020 | 2020/34 Gaz | RU | Ablehnung |
| 13. Juli 2020 | 2020/30 Gaz | IL | Ablehnung |
| 09. Juli 2020 | 2020/28 Gaz | CN | Ablehnung |
| 16. Januar 2020 | 2020/8 Gaz | EM | Eintragung |
ID: 141518503